With 0.87 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.75 million shares. The 52-week range on UTI shows that it touched its highest point at $30.56 and its lowest point at $13.66 during that stretch. It currently has a 1-year price target of $34.00. Beta for the stock currently stands at 1.56.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UTI was up-trending over the past week, with a rise of 5.56%, but this was up by 15.70% over a month. Three-month performance surged to 4.33% while six-month performance rose 78.97%. The stock gained 89.75% in the past year, while it has gained 15.21% so far this year. A look at the trailing 12-month EPS for UTI yields 0.97 with Next year EPS estimates of 1.09. For the next quarter, that number is 0.11. This implies an EPS growth rate of 32.89% for this year and 9.03% for next year.
Float and Shares Shorts:
At present, 54.37 million UTI shares are outstanding with a float of 50.11 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for UTI since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.71603 being high and $0.69835 being low. For UTI, this leads to a yearly average estimate of $0.70833.
